Modafinil is occasionally prescribed off-label for individuals with attention deficit hyperactivity disorder (ADHD). It has shown no efficacy in treating adult ADHD, especially when compared to other treatments such as lisdexamfetamine. In children, modafinil is efficient in treating ADHD symptoms.
Given its approved status in the US to treat narcolepsy, physicians can also prescribe modafinil for off-label uses, such as treating ADHD in both children and adults.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) suggests modafinil as a second-line choice for ADHD, after the first-line choices such as bupropion are exhausted.